{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T17:40:29Z","timestamp":1678383629142},"reference-count":37,"publisher":"Journal of Biomedical Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2019]]},"DOI":"10.7555\/jbr.32.20170085","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T01:49:17Z","timestamp":1541728157000},"page":"258","source":"Crossref","is-referenced-by-count":0,"title":["Effects of milrinone on inflammatory response-related gene expressions in cultured rat cardiomyocytes"],"prefix":"10.7555","volume":"33","author":[{"given":"Archana G.","family":"Venakatesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann J.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longqiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey L.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4380","reference":[{"key":"key-10.7555\/JBR.32.20170085-1","doi-asserted-by":"publisher","unstructured":"Shipley JB, Hess ML.  Inotropic therapy for the failing myocardium[J]. <i>Clin Cardiol, <\/i>1995, 18(11): 615\u2013619.","DOI":"10.1002\/clc.v18:11"},{"key":"key-10.7555\/JBR.32.20170085-2","doi-asserted-by":"crossref","unstructured":"Hunt SA, Abraham WT, Chin MH, et al.  Focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults task force members[J]. <i>JAC, <\/i>2009, 53(15): e1\u2013e90.","DOI":"10.1016\/j.jacc.2008.11.013"},{"key":"key-10.7555\/JBR.32.20170085-3","doi-asserted-by":"publisher","unstructured":"Belletti A, Castro ML, Silvetti S, et al.  The effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials[J]. <i>Br J Anaesth, <\/i>2015, 115(5): 656\u2013675.","DOI":"10.1093\/bja\/aev284"},{"key":"key-10.7555\/JBR.32.20170085-4","doi-asserted-by":"publisher","unstructured":"Jaiswal A, Nguyen VQ, Le Jemtel TH, et al.  Novel role of phosphodiesterase inhibitors in the management of end-stage heart failure[J]. <i>World J Cardiol, <\/i>2016, 8(7): 401\u2013412.","DOI":"10.4330\/wjc.v8.i7.401"},{"key":"key-10.7555\/JBR.32.20170085-5","doi-asserted-by":"publisher","unstructured":"Tang X, Liu P, Li R, et al.  Milrinone for the treatment of acute heart failure after acute myocardial infarction: a systematic review and meta-analysis[J]. <i>Basic Clin Pharmacol Toxicol, <\/i>2015, 117(3): 186\u2013194.","DOI":"10.1111\/bcpt.2015.117.issue-3"},{"key":"key-10.7555\/JBR.32.20170085-6","doi-asserted-by":"publisher","unstructured":"Zangrillo A, Biondi-Zoccai G, Ponschab M, et al.  Milrinone and mortality in adult cardiac surgery: a meta-analysis[J]. <i>J Cardiothorac Vasc Anesth, <\/i>2012, 26(1): 70\u201377.","DOI":"10.1053\/j.jvca.2011.06.022"},{"key":"key-10.7555\/JBR.32.20170085-7","doi-asserted-by":"publisher","unstructured":"Packer M, Carver JR, Rodeheffer RJ, et al.  Effect of oral milrinone on mortality in severe chronic heart failure[J]. <i>N Engl J Med, <\/i>1991, 325(21): 1468\u20131475.","DOI":"10.1056\/NEJM199111213252103"},{"key":"key-10.7555\/JBR.32.20170085-8","doi-asserted-by":"crossref","unstructured":"Chanani NK, Cowan DB, Takeuchi K, et al.  Differential effects of amrinone and milrinone upon myocardial inflammatory signaling[J]. <i>Circulation, <\/i>2002, 106(12 Suppl 1): I284\u2013I289.","DOI":"10.1161\/01.cir.0000032904.33237.8e"},{"key":"key-10.7555\/JBR.32.20170085-9","doi-asserted-by":"crossref","unstructured":"Liu H, Sangkum L, Liu G, et al.  Effects of epinephrine on angiogenesis-related gene expressions in cultured rat cardiomyocytes[J]. <i>J Biomed Res, <\/i>2016, 30(5): 380\u2013385.","DOI":"10.7555\/JBR.30.20160024"},{"key":"key-10.7555\/JBR.32.20170085-10","unstructured":"Chen S, Liu GL, Li MM, et al.  Effects of epinephrine on inflammation-related gene expressions in cultured rat cardiomyocytes[J]. <i>Transl Perioper Pain Med, <\/i>2017, 2(1): 13\u201319."},{"key":"key-10.7555\/JBR.32.20170085-11","doi-asserted-by":"publisher","unstructured":"Zhao F, Li B, Wei YZ, et al.  MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes[J]. <i>J Huazhong Univ Sci Technolog Med Sci, <\/i>2013, 33(6): 834\u2013839.","DOI":"10.1007\/s11596-013-1207-7"},{"key":"key-10.7555\/JBR.32.20170085-12","doi-asserted-by":"publisher","unstructured":"Merten KE, Jiang Y, Feng W, et al.  Calcineurin activation is not necessary for doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway[J]. <i>J Pharmacol Exp Ther, <\/i>2006, 319(2): 934\u2013940.","DOI":"10.1124\/jpet.106.108845"},{"key":"key-10.7555\/JBR.32.20170085-13","doi-asserted-by":"publisher","unstructured":"Hamid T, Xu Y, Ismahil MA, et al.  TNF receptor signaling inhibits cardiomyogenic differentiation of cardiac stem cells and promotes a neuroadrenergic-like fate[J]. <i>Am J PhysiolHear Circ Physiol, <\/i>2016, 311(5): H1189\u2013H1201.","DOI":"10.1152\/ajpheart.00904.2015"},{"key":"key-10.7555\/JBR.32.20170085-14","doi-asserted-by":"publisher","unstructured":"Abu El-Asrar AM, Nawaz MI, Ola MS, et al.  Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy[J]. <i>Acta Ophthalmol, <\/i>2013, 91(3): e169\u2013e177.","DOI":"10.1111\/aos.2013.91.issue-3"},{"key":"key-10.7555\/JBR.32.20170085-15","doi-asserted-by":"publisher","unstructured":"Hanatani S, Izumiya Y, Takashio S, et al.  Circulating thrombospondin-2 reflects disease severity and predicts outcome of heart failure with reduced ejection fraction[J]. <i>Circ J, <\/i>2014, 78(4): 903\u2013910.","DOI":"10.1253\/circj.CJ-13-1221"},{"key":"key-10.7555\/JBR.32.20170085-16","doi-asserted-by":"publisher","unstructured":"Frangogiannis NG, Ren G, Dewald O, et al.  Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts[J]. <i>Circulation, <\/i>2005, 111(22): 2935\u20132942.","DOI":"10.1161\/CIRCULATIONAHA.104.510354"},{"key":"key-10.7555\/JBR.32.20170085-17","doi-asserted-by":"publisher","unstructured":"Schroen B, Heymans S, Sharma U, et al.  Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy[J]. <i>Circ Res, <\/i>2004, 95(5): 515\u2013522.","DOI":"10.1161\/01.RES.0000141019.20332.3e"},{"key":"key-10.7555\/JBR.32.20170085-18","doi-asserted-by":"crossref","unstructured":"Page-McCaw A, Ewald AJ, Werb Z.  Matrix metalloproteinases and the regulation of tissue remodelling[J]. <i>Nat Rev Mol Cell Biol, <\/i>2007, 8(3): 221\u2013233.","DOI":"10.1038\/nrm2125"},{"key":"key-10.7555\/JBR.32.20170085-19","doi-asserted-by":"publisher","unstructured":"Hori Y, Kashimoto T, Yonezawa T, et al.  Matrix metalloproteinase-2 stimulates collagen-I expression through phosphorylation of focal adhesion kinase in rat cardiac fibroblasts[J]. <i>Am J Physiol Cell Physiol, <\/i>2012, 303(9): C947\u2013C953.","DOI":"10.1152\/ajpcell.00401.2011"},{"key":"key-10.7555\/JBR.32.20170085-20","doi-asserted-by":"publisher","unstructured":"Nepomnyashchikh LM, Lushnikova EL, Bakarev MA, et al.  Immunohistochemical analysis of MMP-2 expression in the myocardium during the postinfarction period[J]. <i>Bull Exp Biol Med, <\/i>2015, 159(4): 505\u2013510.","DOI":"10.1007\/s10517-015-3004-8"},{"key":"key-10.7555\/JBR.32.20170085-21","doi-asserted-by":"publisher","unstructured":"Gao L, Zheng YJ, Gu SS, et al.  Degradation of cardiac myosin Milrinone alters inflammation-related gene expression 5light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia\/reperfusion[J]. <i>J Mol Cell Cardiol, <\/i>2014, 77: 102\u2013112.","DOI":"10.1016\/j.yjmcc.2014.10.004"},{"key":"key-10.7555\/JBR.32.20170085-22","doi-asserted-by":"publisher","unstructured":"Libby P.  Collagenases and cracks in the plaque[J]. <i>J Clin Invest, <\/i>2013, 123(8): 3201\u20133203.","DOI":"10.1172\/JCI67526"},{"key":"key-10.7555\/JBR.32.20170085-23","doi-asserted-by":"publisher","unstructured":"Newby AC.  Metalloproteinase production from macrophages- a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction[J]. <i>Exp Physiol, <\/i>2016, 101(11): 1327\u20131337.","DOI":"10.1113\/EP085567"},{"key":"key-10.7555\/JBR.32.20170085-24","doi-asserted-by":"crossref","unstructured":"Kostov K, Blazhev A, Atanasova M, et al.  Serum concentrations of endothelin-1 and matrix metalloproteinases-2, -9 in prehypertensive and hypertensive patients with type 2 diabetes[J]. <i>Int J Mol Sci, <\/i>2016, 17(8): 1\u201313.","DOI":"10.3390\/ijms17081182"},{"key":"key-10.7555\/JBR.32.20170085-25","doi-asserted-by":"publisher","unstructured":"Jiang L, Zhang J, Monticone RE, et al.  Calpain-1 regulation of matrix metalloproteinase 2 activity in vascular smooth muscle cells facilitates age-associated aortic wall calcification and fibrosis[J]. <i>Hypertension, <\/i>2012, 60(5): 1192\u20131199.","DOI":"10.1161\/HYPERTENSIONAHA.112.196840"},{"key":"key-10.7555\/JBR.32.20170085-26","doi-asserted-by":"publisher","unstructured":"Qian J, Chen Z, Lin J, et al.  Decreased expression of CCAAT\/ enhancer binding protein zeta (C\/EBPzeta) in patients with different myeloid diseases[J]. <i>Leuk Res, <\/i>2005, 29(12): 1435\u20131441.","DOI":"10.1016\/j.leukres.2005.05.020"},{"key":"key-10.7555\/JBR.32.20170085-27","doi-asserted-by":"publisher","unstructured":"Lin J, Wang YL, Qian J, et al.  Aberrant methylation of DNAdamage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome[J]. <i>Leuk Res, <\/i>2010, 34(8): 991\u2013994.","DOI":"10.1016\/j.leukres.2010.01.003"},{"key":"key-10.7555\/JBR.32.20170085-28","doi-asserted-by":"publisher","unstructured":"Xu Y, Chen Z, Zhang G, et al.  HSP90B1 overexpression predicts poor prognosis in NSCLC patients[J]. <i>Tumour Biol, <\/i>2016, 37(10): 14321\u201314328.","DOI":"10.1007\/s13277-016-5304-7"},{"key":"key-10.7555\/JBR.32.20170085-29","doi-asserted-by":"publisher","unstructured":"Shneyvays V, Zinman T, Shainberg A.  Analysis of calcium responses mediated by the A3 adenosine receptor in cultured newborn rat cardiac myocytes[J]. <i>Cell Calcium, <\/i>2004, 36(5): 387\u2013396.","DOI":"10.1016\/j.ceca.2004.03.004"},{"key":"key-10.7555\/JBR.32.20170085-30","doi-asserted-by":"publisher","unstructured":"Galal A, El-Bakly WM, Al Haleem EN, et al.  Selective A3 adenosine receptor agonist protects against doxorubicininduced cardiotoxicity[J]. <i>Cancer Chemother Pharmacol, <\/i>2016, 77(2): 309\u2013322.","DOI":"10.1007\/s00280-015-2937-y"},{"key":"key-10.7555\/JBR.32.20170085-31","doi-asserted-by":"publisher","unstructured":"Lu Z, Fassett J, Xu X, et al.  Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure overloaded left ventricle[J]. <i>Circulation, <\/i>2008, 118(17): 1713\u20131721.","DOI":"10.1161\/CIRCULATIONAHA.108.788307"},{"key":"key-10.7555\/JBR.32.20170085-32","doi-asserted-by":"publisher","unstructured":"Kahles F, Findeisen HM, Bruemmer D.  Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes[J]. <i>Mol Metab, <\/i>2014, 3(4): 384\u2013393.","DOI":"10.1016\/j.molmet.2014.03.004"},{"key":"key-10.7555\/JBR.32.20170085-33","doi-asserted-by":"publisher","unstructured":"Meng C, Liu Z, Liu GL, et al.  Ketamine promotes inflammation through increasing TLR4 expression in RAW264.7 cells[J]. <i>J Huazhong Univ Sci Technolog Med Sci, <\/i>2015, 35(3): 419\u2013425.","DOI":"10.1007\/s11596-015-1447-9"},{"key":"key-10.7555\/JBR.32.20170085-34","doi-asserted-by":"crossref","unstructured":"Lund H, Boysen P, \u00c5kesson CP, et al.  Transient migration of large numbers of CD14(++) CD16(+) monocytes to the draining lymph node after onset of inflammation[J]. <i>Front Immunol, <\/i>2016, 7: 322.","DOI":"10.3389\/fimmu.2016.00322"},{"key":"key-10.7555\/JBR.32.20170085-35","doi-asserted-by":"crossref","unstructured":"Krasity BC, Troll JV, Lehnert EM, et al.  Structural and functional features of a developmentally regulated lipopolysaccharide-binding protein[J]. <i>MBio, <\/i>2015, 6(5): e01193\u201315.","DOI":"10.1128\/mBio.01193-15"},{"key":"key-10.7555\/JBR.32.20170085-36","doi-asserted-by":"publisher","unstructured":"Friedrich K, Smit M, Brune M, et al.  CD14 is associated with biliary stricture formation[J]. <i>Hepatology, <\/i>2016, 64(3): 843\u2013852.","DOI":"10.1002\/hep.v64.3"},{"key":"key-10.7555\/JBR.32.20170085-37","doi-asserted-by":"publisher","unstructured":"Guillou C, Fr\u00e9ret M, Fondard E, et al.  Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function[J]. <i>Sci Rep, <\/i>2016, 6: 23796.","DOI":"10.1038\/srep23796"}],"container-title":["The Journal of Biomedical Research"],"original-title":[],"link":[{"URL":"http:\/\/www.jbr-pub.org.cn\/fileSWYXYJZZYWB\/journal\/article\/swyxyjzzywb\/2019\/4\/JBR-2017-0085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T17:15:50Z","timestamp":1678382150000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.32.20170085?viewType=HTML"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["JBR-2017-0085"],"URL":"https:\/\/doi.org\/10.7555\/jbr.32.20170085","relation":{},"ISSN":["1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}